πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 124 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7442696

Mineralocorticoid receptor modulator compounds, processes for their preparation, and their

Ligand Pharmaceuticals Incorporated Β· Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7439027

Method for modulating process mediated by farnesoid activated receptors

Ligand Pharmaceuticals Incorporated Β· Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7435733

Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical composition

Ligand Pharmaceuticals Incorporated Β· Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7348359

Retinoid X receptor modulators

Ligand Pharmaceuticals Incorporated Β· Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7314887

Thrombopoietin activity modulating compounds and methods

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7241783

Thrombopoietin mimetics

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jul 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7214690

Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and me

Ligand Pharmaceuticals Incorporated Β· Granted Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7192982

Modulators of peroxisome proliferator activated receptors

Ligand Pharmaceuticals Incorporated Β· Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7163946

5-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7115728

Human peroxisome proliferator activated receptor Ξ³

Ligand Pharmaceuticals Incorporated Β· Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7098025

Human peroxisome proliferator activated receptor gamma (pparΞ³) gene regulatory sequences a

Ligand Pharmaceuticals Incorporated Β· Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7084151

5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno[3,4-Ζ’]quinolines as select

Ligand Pharmaceuticals Incorporated Β· Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7081457

Cyclothiocarbamate derivatives as progesterone receptor modulators

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jul 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7071205

5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7056954

Means for the modulation of processes mediated by retinoid receptors and compounds useful

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7026484

Tricyclic androgen receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated Β· Granted Tue Apr 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6992108

Means for the modulation of processes mediated by retinoid receptors and compounds useful

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jan 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6982261

Cyanopyrroles

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jan 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6964973

Bicyclic androgen and progesterone receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated Β· Granted Tue Nov 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6951942

Glucocorticoid-selective anti-inflammatory agents

Ligand Pharmaceuticals Incorporated Β· Granted Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6946454

Thio-oxindole derivatives

Ligand Pharmaceuticals Incorporated Β· Granted Tue Sep 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6841568

Thio-oxindole derivatives

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jan 11 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6835744

3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated Β· Granted Tue Dec 28 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6825222

Modulators of peroxisome proliferator activated receptors

Ligand Pharmaceuticals Incorporated Β· Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired